MUDr. Dana Maňasková

  • medicinman.cz
  • Zájmy a činnosti
  • Nemoci a symptomy
  • Léky, látky a laboratorní testy
  • Postupy, metody a terapie
  • Dietologie a potravinářství
  • P-o-traviny, rostliny aj.
  • Papírování
  • Zajímaví lidé a činnosti
  • Odborná pracoviště
  • Odborné odkazy
  • Obecné odkazy a tipy
  • Kalendář akcí
  • CV a kredity
  • Fantazie, nápady a snění
  • GDPR

Vyhledávání na medicinman.cz
 

Cystein

  • Cysteine cannot be administered intravenously due to its toxic effects on the system [1]
    • All the amino acids contained in the basic solutions, the only one containing sulphur is L-methionine
    • Methionine is metabolized only in the liver [1]
      • Malfunctioning or partially functioning liver [1]
  • Method for introducing cysteine which can be metabolized as well in organs other than the liver [1]
    • L-2-oxothiazolidine-4-carboxylic acid (OTC) [1]
      • Administration of the thiazolidine stimulated the formation of glutathione to levels that are about twice those of the controls [1]

N-acetylcystein

  • Metabolized to cysteine in the kidney
  • Then transported to the liver or peripheral cells
  • May not be sufficiently distributed to the requisite tissues of the patient, i.e., the tissue of the lungs. !!! [2]
    • Vázne zabezpečení zdroje glutathionu pro pneumocyty v kritickém stavu (ARDS)

L-2-oxothiazolidine-4-carboxylate and glutathione esters

  • Při ARDS
  • Thiazolidine-4-carboxylate analogs that are converted intracellulary to glutathione can be utilized. [2]
  • L-2-oxothiazolidine-4-carboxylate
    • 5-oxo-L-prolinase in the presence of adenosine triphosphate produce S-carboxyl cysteine
      • Decarboxylated to produce cysteine
        • Metabolized to provide glutathione [2]
Literatura:

[1] Patent EP0057942B1 - Cysteine delivery system - Patenty Google [Internet]. [citován 31. květen 2013]. Dostupné od: www.google.com/patents/EP0057942B1?cl=en&hl=cs&dq=%2215454-75-8%22+OR+%225-oxoproline%22+OR+%22proline,+5-oxo-%22+OR+%225-Carboxy-2-pyrrolidinone%22+OR+%225-Oxo-2-pyrrolidincarbons%C3%A4ure%22+OR+%222-Pyrrolidone-5-carboxylic+acid+%22+OR+%225-OXO-2-PYRROLIDINECARBOXYLIC+ACID%22&source=uds
[2] Patent US5824693 - Method for treatment for pulmonary disease - Patenty Google [Internet]. [citován 4. červen 2013]. Dostupné od: www.google.com/patents/US5824693?hl=cs&dq=%2215454-75-8%22+OR+%225-oxoproline%22+OR+%22proline,+5-oxo-%22+OR+%225-Carboxy-2-pyrrolidinone%22+OR+%225-Oxo-2-pyrrolidincarbons%C3%A4ure%22+OR+%222-Pyrrolidone-5-carboxylic+acid+%22+OR+%225-OXO-2-PYRROLIDINECARBOXYLIC+ACID%22



O úroveň výše

Poslední aktualizace: 20. 7. 2013 17:57:37
© Dana Maňasková, metabalance.cz
e-mail